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Antimicrobial stewardship knowledge and perception among physicians and 
pharmacists at leading tertiary teaching hospitals in Zambia: implications 
for future policy and practice  
 
Abstract 
Background: Antimicrobial stewardship (AMS) is a key strategy 
promoting rational antimicrobial use. In Zambia, information on health 
professionals’ knowledge, attitude, and practice of AMS is limited. This 
study was undertaken to address this at Zambia’s leading specialised 
teaching hospitals. Methods: Descriptive, cross-sectional study involving 
137 physicians and 61 pharmacists. Results: AMS knowledge was 
relatively low among physicians (51%) and pharmacists (39%). Few 
physicians (9%) and pharmacists (20%) demonstrated sufficient knowledge 
of the basic principles of AMS. Physicians’ and pharmacists’ knowledge 
levels were significantly associated with years of practice, job position or 
practice rank, and previous AMS training.  The majority (95%) perceived 
AMR as a current problem in their practise. Most physicians (92%) and 
pharmacists (86%) had not undertaken AMS training before. All indicated 
the need for context-specific educational interventions to promote AMS in 
Zambia. Conclusion: Despite positive perceptions, basic knowledge of 
AMS was relatively low. Context-specific educational interventions and 
capacity building are needed to address AMS gaps.  
 
Keywords: Antimicrobial stewardship, knowledge, perceptions, physicians, pharmacists, 
Zambia 
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Introduction 
Antimicrobial resistance (AMR) is a major public health concern increasing morbidity, 
mortality, and costs (1-5). The increasing inappropriate use of antibiotics driving AMR has led 
to international, regional and national initiatives to address this concern (6-10). AMR is one of 
the most important challenges facing healthcare systems worldwide (4, 6, 11, 12). If left 
unattended, an estimated 10 to 444 million people will die annually from AMR by 2050, 
appreciably reducing gross domestic product (GDP) among countries (3, 4, 10). Inappropriate 
use of antibiotics includes their inappropriate prescribing and dispensing (13-16). In low and 
middle-income countries (LMICs), antimicrobial use is increasing, yet in many cases antibiotic 
use is inappropriate or suboptimal, enhanced by the lack of adequate surveillance systems and 
governance (9, 12, 17-22). In addition, there is considerable self-purchasing of antibiotics 
among patients in LMICs often for viral infections such as upper respiratory tract infections 
(16, 23-27).  
AMR poses a particular health risk in LMICs compared to higher income countries due 
to the double burden of communicable and non-communicable diseases (10, 28-30), including 
increased risk of life-threatening infectious diseases such as HIV, tuberculosis, pneumonia, and 
malaria (31-33). Consequently, it is imperative to improve the prescribing and dispensing of 
antimicrobials in LMICs.  
The instigation of antimicrobial stewardship (AMS) at health service delivery points 
particularly in hospitals is a recognised strategy to improve antimicrobial use and arrest 
growing AMR rates (34-39). However, recognising that AMS programmes are particularly 
challenging in LMICs due to health structure issues as well as lack of implementation of 
policies (40). AMS programmes though enable coordinated interventions designed to improve 
and measure appropriate use of antimicrobials through formulary development, promoting the 
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optimal selection of antimicrobial drug regimens and their treatment duration, as well as 
promoting optimal routes of administration. AMS programmes are also known to improve the 
quality of patient care by reducing adverse events and improving patient outcomes (35, 37, 40). 
In addition, AMS programmes reduce AMR and the spread of infections caused by multidrug-
resistant organisms (41). Already in 2003, Carling and colleagues (42) have documented the 
benefits of good AMS in hospital settings whereby a well implemented multidisciplinary AMS 
programme consistently demonstrated a decrease in the incidence of Clostridioides difficile–
associated diarrhoea. Studies have also promoted key stakeholder groups in LMICs such as 
pharmacists to develop guidelines for AMS programmes (43) to improve subsequent 
antimicrobial use, especially in hospitals. 
In Zambia, high rates of irrational antimicrobial prescribing and dispensing have been 
reported (44), with most antibiotics prescribed in hospitals without bacteriological tests (45) 
similar to a number of other LMICs (46-50).  There are also high rates of self-purchasing of 
antibiotics without prescription in Zambia adding to AMR rates (24). However, to develop and 
provide potential initiatives to address irrational antimicrobial use in Zambia, there is a need to 
identify and address knowledge gaps including practice and behaviours of healthcare providers, 
which may be driving up AMR rates (51). We are aware through previous research by other 
scholars that there is variable knowledge of antibiotics and AMR among key stakeholder 
groups including physicians and pharmacists (52-63), with pharmacists typically being a 
member of AMS groups within hospitals (35, 64, 65). Lack of knowledge about antibiotic 
utilisation, AMR and AMS practice is a concern in the local setting. Knowledgeable physicians 
and pharmacists are crucial to the success of any AMS programme through developing and 
implementing appropriate antimicrobial strategies in their health facilities.  
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Prior to this study, it was not known how existing knowledge of AMS and perceptions 
of AMR, or lack of it, could be influencing antimicrobial utilization in Zambia. This study was 
seen as important given the high burden of infectious diseases in Zambia including HIV/AIDS, 
tuberculosis, malaria, and pneumonia (24), as well as concerns about the lack of AMS 
programmes in a number of African countries (40, 66). Consequently, data on the existing 
knowledge and perceptions of AMS concepts among key health professionals was essential as 
a starting point to evaluate the need and nature for appropriate educational interventions to 
improve future antimicrobial utilisation in Zambia. Consequently, as a first step, this study 
explored physicians’ and pharmacists’ knowledge and perceptions regarding AMS at leading 
tertiary teaching hospitals in Zambia.  
 
Methods 
Study Design and Sites 
A cross-sectional study employing quantitative methods was undertaken.  
The University Teaching Hospitals (UTH) in Lusaka Zambia, were chosen for this 
initial study. This was because UTH are Zambia’s highest tertiary care referral public hospitals. 
They comprise a consortium of five specialised teaching hospitals namely: The Children’s 
hospital; Mother and New-born hospital; Eye hospital; Adult hospital, and the Cancer Diseases 
hospital, respectively. The assumption was that if there were concerns regarding knowledge of 
AMS and AMR at this level of health care, these were likely to be greater at lower secondary 
care hospitals as well as primary healthcare centres in Zambia. 
Physicians and pharmacists practising at UTH were the population of interest as they 
are key health professionals directly involved in prescribing and dispensing antimicrobials in 
the hospitals. Moreover, by practising at the respective university teaching hospitals, they are 
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also involved in teaching and mentoring undergraduate students, which are tomorrow’s health 
professionals.    
Sample Size 
The sample size of physicians and pharmacists were independently determined using 
Yamane’s formula (67) where the total population of physicians at UTH stood at 210 and 85 
pharmacists respectively at the time of the study. Using a confidence level of 95%, and a margin 
of error of 5%, the computed sample size was 137 physicians and 70 pharmacists, respectively.   
Data Collection and Instruments  
A structured self-administered questionnaire was used to collect data on the following 
aspects: (i) participants’ demographics; (ii) general knowledge on AMS; (iii) knowledge of the 
goals, objectives, and development strategies of AMS; (iv) perceptions and attitudes about 
antimicrobial utilisation and AMR; and (v) the perceived need for AMS training. The 
questionnaire was adapted from similar studies undertaken by Abbo and colleagues (68, 69). 
The questionnaire was piloted for consistency, length, and relevance of the questions among 
five physicians and five intern pharmacists at the Levy Mwanawasa Hospital in Lusaka during 
February 2017 and further refined. A total of 207 questionnaires were sent out and field data 
collection conducted from April to June 2017. 
Data Analysis 
Descriptive statistics were employed to analyse the data. Contingency tables were 
generated for frequencies and proportions of categorical variables. AMS knowledge scores 
were initially rated on a continuous scale out of 10. Subsequently, scores were categorized into 
three levels for ease of comparison and interpretation. These included: a 0 to 4 score as ‘low’, 
a 5 to 7 score as ‘moderate’ and an 8 to 10 score as ‘high’ knowledge level, respectively. Any 
6 
 
associations between AMS knowledge and demographic variables were determined using the 
Freeman-Halton extension Fisher’s exact test. For statistical inference, a p-value of less than 
0.05 was accepted as a statistically significant association. Likert scores for the perception data 
were summed and grouped into ‘agreed’, ‘unsure’ and ‘disagreed’ categories, respectively. 
Numerical values of the 5-point Likert scale were grouped as follows: rating 1 and 2 = 
‘disagreed’, 3 = ‘unsure’, and 4 and 5 = ‘agreed’. Depending on the nature of the statement 
asked, responses in agreement or disagreement were categorized as positive and negative 
perceptions accordingly. Stata 13 software (Stata Corp, College Station, TX, USA) was used 
for statistical analysis. 
Ethical Considerations 
Written informed consent was obtained from each participant prior to enrolment in the 
study. Completion of the questionnaires was anonymous and data confidentially maintained. 
The study posed no known risk to participants. Ethical approval for this study was obtained 
from the University of Zambia, School of Medicine Research Ethics Committee (IRB00001131 
of IORG0000774). Formal permission to collect data was obtained from the hospital 
management at each respective site accordingly.    
 
Results 
Participants Demographics 
A total of 198 participants enrolled included 137  physicians and 61 pharmacists (95% 
response rate). Table 1 shows the demographic characteristics of the participants. 
 
INSERT TABLE 1 
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Participants were mostly intern and resident physicians and pharmacists, and the 
majority of participants (55%) had less than five professional years of work experience (Table 
1). There were a limited number of consultant-level physicians and clinical specialists in the 
sample, with few physicians (14%) and pharmacists having more than ten professional years 
of practice experience (14%). There was a relatively higher rate of refusal to participate in the 
study among senior ranked physicians and pharmacists than those in lower ranks. There were 
more participants from the Adult hospital which is currently the largest hospital among the 
UTH consortium and houses departments such as Internal Medicine, Surgery, Emergency and 
Critical Care, and the Adult Infectious Diseases Centre, respectively. 
Antimicrobial Stewardship knowledge  
Half (51%) of the physicians and 39% of the pharmacists indicated that they did not 
know what AMS was. Among those that indicated they knew what AMS was, only 9% of the 
physicians and 20% of the pharmacists demonstrated sufficient knowledge regarding the basic 
principles of AMS programmes. Knowledge levels were significantly associated with 
practitioners’ years of professional practice, position, or practice rank, and having undertaken 
previous AMS training (Table 2).   
 
INSERT TABLE 2 
 
Perceptions of Antimicrobial Use and Antimicrobial resistance (AMR) 
Table 3 shows that the majority of participants had correct perceptions of and attitudes 
towards antimicrobial use and AMR in general. All participants (100%) agreed that 
inappropriate use of antimicrobials needs to be curbed, and the majority recognized AMR as a 
problem in their daily practice.    
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INSERT TABLE 3 
 
Antimicrobial Stewardship training  
Only 8% of the 137 physicians surveyed indicated they had previously undertaken 
AMS training programmes elsewhere, whilst only 11% out of 61 pharmacists indicated 
similarly. Nearly all participants (98%) stated that they were not aware of any active AMS 
programmes in place at the hospital sites at the time of the survey. All participants (100%) 
agreed that there was a need for active and contextually-relevant AMS programmes and 
capacity-building at UTH. Table 4 shows the participants’ preferred modes of AMS training.  
 
INSERT TABLE 4 
 
Training workshops were the most preferred mode of AMS capacity building and 
professional development for the majority (>50%) of the participants, followed by on the job 
hands-on training. Short courses and self-paced online courses were least preferred (Table 4).   
 
Discussion 
This study explored physicians’ and pharmacists’ knowledge and perceptions of AMS at 
leading tertiary teaching hospitals in Zambia using a descriptive cross-sectional survey.  
Antimicrobial Stewardship knowledge levels as well as general knowledge on AMR 
We believe this is the first study to explore physicians’ and pharmacists’ knowledge 
and perceptions on AMS at leading university teaching hospitals in Zambia. Of concern was 
that this study found relatively low levels of conceptual knowledge on basic AMS principles 
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and concepts assessed among physicians and pharmacists practicing at this consortium of 
leading referral teaching hospitals in Zambia. Overall, half (51%) of the physicians and 39% 
of the pharmacists at the teaching hospitals did not know about AMS (Table 2). It could be 
argued that these low levels of knowledge could be attributed to the fact that AMS was 
relatively a new concept coming to the fore in Zambia, which needs to be urgently addressed. 
Notwithstanding the generally low conceptual knowledge of AMS, encouragingly a 
much higher proportion of participants perceived that irrational antimicrobial use should be 
curbed, that it is a problem in their current practice, and they should consider sensitivity 
patterns when using antimicrobials (Table 3). This suggests that some aspects of AMS are 
informally known and practiced but perhaps not conceptually understood and formalised. Lack 
of or limited implementation of Antimicrobial Stewardship Programmes (ASPs) due to limited 
resources among tertiary hospitals (70), as recently evidenced in Nigeria (66), could also 
explain the existing knowledge gap among physicians and pharmacists in Zambia.  This is 
despite the concept of AMS programmes being an accepted global strategy to improve 
antimicrobial prescribing, especially in hospitals, to prevent AMR though recognising 
particular challenges in LMICs (39, 40, 71).  
Similarly, inadequate knowledge about rational antimicrobial use is an issue that has 
been identified in other LMICs. Donkor and colleagues found that just under half of the 
students at tertiary level facilities in Ghana had poor knowledge about the irrational use of 
antibiotics (72). A lack of knowledge of antibiotics and resistance was highlighted among 
pharmacy students and physicians in India and Pakistan, with the majority of physicians 
admitting to no training on rational antibiotic use (63, 73, 74). Similarly, there were concerns 
about the level of knowledge of antibiotics and AMR among medical students in South Africa 
(75) as well as appreciable differences in the knowledge and perception of AMS programmes 
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among final year pharmacy students in South Africa (62). The majority of physicians and 
nurses in Ethiopia also lack knowledge about antimicrobials and AMR (60), with physicians 
in Saudi Arabia believing education and adherence to guidelines can reduce AMR rates in 
hospitals (61). There have also been concerns regarding antibiotic prescribing and knowledge 
about AMR among physicians in tertiary facilities in Ghana and Nigeria, with prescribing 
influenced by pharmaceutical company representatives in Nigeria (46, 76). This contrasts with 
Namibia where the majority of antibiotic prescribing in hospitals complied with national 
guidelines, although lower than the target rate of 95% (30).  
The low levels of AMS knowledge in our study further highlight a gap that needs to be 
addressed through high impact educational interventions in the short-term among hospitals in 
Zambia as well as embedding AMS and associated programmes into health professionals’ 
education curricula both at undergraduate and postgraduate levels. Going forward, AMS needs 
to be a priority among health professional’s education programmes at all levels in Zambia as a 
sustainable measure given the current high rates of infectious diseases in Zambia. Burger and 
colleagues (62) in their study in South Africa also concluded that in order to help prevent AMR, 
efforts should be made to introduce concepts of AMS into the undergraduate pharmacy 
curricula to promote better use of antimicrobials and prevent AMR. This is being supported by 
newly developed guidelines on pharmacists’ roles in AMS programmes in South Africa (43).  
Whilst education is a pillar of any AMS strategy, we believe similarly to John and 
Fishman (77) that AMS educational programmes must be context specific and address local 
needs. This is important especially given the challenges of introducing AMS programmes 
among LMICs versus higher income countries, and reflects the complex nature of 
implementing AMS programmes in LMICs (40). There are also contextual variations regarding 
what constitutes an optimal educational programme on AMS in different country settings. For 
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example, educational programmes on AMS can range from one-to-one instructions to formal 
approaches including workshops, lectures, staff conferences, clinical pharmacy consultations, 
and drug utilisation evaluations (77).  
Our study revealed that the majority of physicians and pharmacists at UTH preferred 
formalized educational approaches such as structured training workshops on AMS whereas 
others preferred on the job hands-on training (Table 4). Further research is needed to explore 
how effective an educational intervention blending multidisciplinary learning through 
structured workshops, and on-the-job hands-on training methods, will be to improve 
knowledge about AMS as well as improving antibiotic prescribing in Zambia. These are 
projects for the future.   
Perceptions of Antimicrobial Stewardship 
Encouragingly, the majority of physicians and pharmacists in this study appreciated the 
importance of rational antimicrobial use and AMR (Table 3). There was also no difference in 
perceptions among physicians and pharmacists. Our findings complement those of Abbo and 
colleagues (68), who found positive perceptions among nurse practitioners and physicians in 
Florida, USA, regarding antibiotics and AMR. Similarly, our study found that physicians and 
pharmacists at UTH in Zambia were aware of and concerned about irrational antimicrobial use. 
Most participants agreed that inappropriate use of antimicrobials needs to be curbed and that 
rational use of antimicrobials can prevent AMR (Table 3).  
There was however disagreement among some physicians and pharmacists on basing 
prescribing and the choice of antimicrobial on local antimicrobial policy and guidelines, which 
may reflect gaps in the levels of trust and confidence they have in existing policies and 
guidelines on antimicrobial use. This may also reflect a paramount need for health 
policymakers to regularly update and implement evidence-based antimicrobial policies and 
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guidelines that health professionals will have confidence and trust adhering to. Trust in 
guidelines enhances their use (78). Recent evidence also suggests antibiotic decision-making 
is a social process dependent on cultural and contextual factors. Cultural boundaries in health 
care and across specialties still limits the involvement of allied health professionals in 
stewardship interventions (70), which needs to be addressed going forward. 
We believe the importance of such positive perceptions cannot be understated as 
behavioural changes among prescribers and dispensers of antimicrobials will be essential to 
enhance the prudent and rational use of antimicrobials in the future. Positive perceptions are 
essential to address variable adherence to guidelines and educational activities that currently 
exist across countries (30, 57, 79-83). As a result of our findings, we believe concerted efforts 
and educational strategies are needed at UTH to reduce the unjustified high rate of 
antimicrobial prescribing reported by Mudenda and colleagues (44). Undoubtedly, 
strengthening AMS practices through capacity-building is an urgent need in Zambia. The 
recognition of the importance of preventing AMR must be complemented by AMS 
programmes that enhance knowledge building about the extent of activities needed, and 
behavioural change strategies instigated, to ensure AMS programmes are effectively 
implemented starting in tertiary level teaching hospitals. These are programmes and research 
projects for the future. Overall, Zambia stands to benefit in reducing current AMR rates if 
capacity is built not only among prescribers and dispensers of antimicrobials but among all 
health professionals and the public in general.     
Implications for future policy and practice 
The low knowledge levels and positive views regarding AMS among physicians and 
pharmacists in Zambia needs to be further improved using locally-driven, context-specific and 
needs-based educational interventions. For example, educators of health professionals need to 
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consider incorporating AMS in the undergraduate training programmes as well as introducing 
Continuous Professional Development programmes (CPD) for health professionals once 
qualified that can help build capacity. Leveraging educational opportunities to improve 
knowledge and practice of AMS among healthcare providers is a key strategy to reduce AMR 
in Zambia. Whereas previous and current local strategies in Zambia have largely focused on 
raising awareness on AMR (84), evidence-based educational strategies to promote AMS 
practice and capacity have not yet been tried in Zambia.  
Generally, we believe there is an imminent need for policy and practice to prioritise 
AMS at health service delivery points in Zambia. Implementation of a national multi-sector 
action plan for AMR (84) by the government of Zambia demonstrates efforts being made 
towards addressing this need. Developing high coverage and high impact educational 
interventions using evidence-based behaviour change models alongside, as well as 
strengthening institutional frameworks and tools that enable effective implementation of AMS 
practices, can go a long way to enable health professionals to prudently and rationally utilize 
antimicrobials, thereby averting the spread of AMR in Zambia. Evidence shows that well 
implemented and targeted educational interventions are key to reducing AMR in LMICs (62). 
Further evidence suggests that if well designed and implemented, AMS strategies result in 
considerable benefits not only to the health system but also to patients (42). 
Limitations of the study 
We acknowledge that only physicians and pharmacists at the five specialized tertiary 
hospitals that constitute UTH were surveyed in this study. The study sample considered only a 
component of the professionals that make up the health workforce in Zambia. Though our 
findings may not be generalized to all health professionals throughout Zambia, we remain 
confident that the findings were likely to be similar in other local healthcare facilities. It will 
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be interesting to monitor how AMS knowledge and perceptions of other health workers other 
than physicians and pharmacists compare. This is potentially future work.  
Due to limited resources, other tertiary teaching hospitals around Zambia were not 
surveyed. However, since the UTH represented the highest level of specialised tertiary care 
service delivery in Zambia’s healthcare system, and the facilities being public university 
teaching hospitals, our findings emphasising the urgency to address identified AMS knowledge 
and practice gaps should be applicable to other hospital settings in Zambia. Inherently, the 
cross-sectional study design was unable to establish temporality of knowledge and perception 
variables, and was unable to track relative changes in these and other parameters. Despite these 
limitations, we however believe our study findings provide valuable baseline data for future 
comparative, longitudinal and time-series evaluations. 
 
Conclusion 
Despite overall positive perceptions, there was relatively low conceptual knowledge of 
AMS among physicians and pharmacists at leading tertiary specialized teaching hospitals in 
Zambia. The majority of health professionals have not undertaken AMS training before. These 
knowledge gaps may significantly affect the prudent and rational antimicrobial utilization in 
Zambia enhancing AMR rates. There is an urgent need for AMS training and capacity-building 
to address knowledge and practice gaps in Zambia if the country is to make positive strides in 
improving rational antimicrobial use among all health professionals. The findings from this 
study will be used to design appropriate interventions and initiatives to optimize future AMS 
programmes throughout Zambia to improve antimicrobial use. These interventions are starting 
to be implemented and will be followed up in the future. This may lead the way for other 
LMICs, with similar challenges.  
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Tables 
Table 1: Demographic characteristics of participants  
 
Characteristic Physicians (n, %) Pharmacists (n, %) 
Sex 
• Male 
• Female 
 
80 (58%) 
57 (42%) 
 
26 (43%) 
35 (57%) 
Years of Practice 
• <5 years 
• 5 to 10 years 
• >10 years 
 
81 (59%) 
37 (27%) 
19 (14%) 
 
28 (46%) 
24 (39%) 
  9 (15%) 
Position/Practice Rank 
• Intern 
• Resident 
• Senior  
• Consultant/Clinical Specialist 
 
58 (42%) 
55 (40%) 
10 (7%) 
14 (10%) 
 
28 (46%) 
21 (34%) 
 9 (15%) 
 3 (5%) 
Hospital 
• Adult hospital 
• Children’s hospital 
• Mother and New-born hospital 
 
98 (71%) 
22 (16%) 
17 (12%) 
 
 
47 (77%)  
5 (8%) 
9 (15%) 
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Table 2: Physicians and pharmacists’ knowledge on AMS concepts 
 
 
Physicians Pharmacists 
AMS Knowledge 
None Moderate High None Moderate High 
Years of Practice 
• ≤5 years 56 (41%) 22 (16%) 3 (2%) 21 (34%) 17 (28%) 4 (7%) 
• >5 years 14 (10%) 33 (24%) 9 (7%) 3 (5%) 8 (13%) 8 (13%) 
p < 0.0001**** p = 0.0042** 
Position/Practice Rank 
• Junior Officer 
(Intern/Resident) 
68 (50%) 39 (28%) 6 (4%) 23 (38%) 19 (31%) 7 (11%) 
 Senior Officer 
(Senior/Clinical 
Specialist) 
2 (1%) 16 (12%) 6 (4%) 1 (2%) 6 (10%) 5 (8%) 
p < 0.0001**** p = 0.018* 
Previous AMS training  
 Have Ever 
Undertaken 
AMS Training 
0 (0%) 7 (5%) 4 (3%) 0 (0%) 4 (7%) 3 (5%) 
 Never 
Undertaken 
AMS Training 
70 (51%) 48 (35%) 8 (6%) 24 (39%) 21 (34%) 9 (15%) 
p < 0.0001*** p = 0.029* 
*Freeman-Halton extension Fisher’s exact test  
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Table 3: Participants’ perceptions and attitudes towards antimicrobial use and AMR 
  
Physicians (n, %) Pharmacists (n, %) 
Disagreed Unsure Agreed Disagreed Unsure Agreed 
Inappropriate use of antimicrobials 
needs to be curbed 
0 0 137 
(100%) 
0 0 61 
(100%) 
Antimicrobial resistance is 
currently NOT a problem in my 
daily practice 
129 
(94%) 
8 
(6%) 
0 59 
(97%) 
2 
(3%) 
0 
I consider microbial sensitivity 
patterns when selecting 
antimicrobials for treatment of a 
patient 
5 
(4%) 
17 
(12%) 
115 
(84%) 
2 
(3%) 
8 
(13%) 
51 
(84%) 
Rational use of antimicrobials can 
prevent antimicrobial resistance 
1 
(1%) 
3 
(2%) 
133 
(97%) 
4 
(7%) 
0 57 
(93%) 
Choice of antimicrobial use should 
be based on 
laboratory/microbiology test 
results 
15 
(11%) 
30 
(22%) 
92 
(67%) 
6 
(10%) 
8 
(13%) 
47 
(77%) 
Choice of antimicrobial to use 
must be based on hospital 
antimicrobial policy/guidelines 
17 
(12%) 
18 
(13%) 
102 
(74%) 
2 
(3%) 
4 
(7%) 
55 
(90%) 
Choice of antimicrobial to use 
should be based on antimicrobial 
medicines available in the 
Pharmacy 
16 
(12%) 
10 
(7%) 
111 
(81%) 
22 
(36%) 
7 
(11%) 
32 
(52%) 
Choice of antimicrobial used 
should be based on the severity of 
infection 
0 4 
(3%) 
133 
(97%) 
0 5 
(8%) 
56 
(92%) 
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Table 4: Participants’ preferred mode of AMS training 
 
Mode of AMS training preferred: Physicians (n = 137) Pharmacists (n = 61) 
 Training workshops  51% 54% 
 On the job hands-on training 24% 25% 
 Short course (4 – 6 weeks) 11% 16% 
 Self-paced online course 14% 5% 
  
 
 
 
